Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. AstraZeneca Nijmegen B.V.
483
•AstraZeneca Nijmegen B.V.•September 19, 2019

FDA 483 - AstraZeneca Nijmegen B.V. - September 19, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of MedImmune Pharma BV in Nijmegen, The Netherlands, revealed two significant observations related to drug product manufacturing. The firm was cited for inadequate deviation investigations, specifically regarding failed HEPA filters without a proper product impact assessment. Additionally, operators failed to follow procedures designed to prevent microbiological contamination of sterile drug products, exhibiting poor aseptic technique.

Company
AstraZeneca Nijmegen B.V.
Inspection Date
September 19, 2019
Product Type
Drugs
Office
International Compliance Team
Person
  • Thuy T. Nguyen ( Investigator, Consumer Safety Officer)
Open in Dashboard

ID · cfae0374-c679-4edd-9838-4f8b3339c100

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.